Regardless of cancer, since the early 90 s, aberrant levels of PAPP-A have been known to indicate unfavorable pregnancy outcomes such as Down’s syndrome, low birth weights, preeclampsia, growth retardations and other chromosomal abnormalities [58–60]. This evidence concerns the gene PAPPA and cancer.